<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02646878</url>
  </required_header>
  <id_info>
    <org_study_id>CEP310</org_study_id>
    <nct_id>NCT02646878</nct_id>
  </id_info>
  <brief_title>A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics</brief_title>
  <official_title>A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Diabetes</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Diabetes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the performance of the Harmony 1 Sensor in
      subjects age 14 - 75 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a multi-center, prospective single-sample correlational design without controls.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Business decision
  </why_stopped>
  <start_date type="Anticipated">January 2016</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>24 hour calibration requirement</measure>
    <time_frame>10 days</time_frame>
    <description>Descriptive summary of sensor accuracy for Harmony 1 Sensor data with the every 24 hour calibration requirements</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Harmony 1 Sensor Group A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects wearing Harmony 1 Sensor will be assigned this group which will participate in the in-clinic YSI frequent sample testing 90 minutes after sensor insertion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Harmony 1 Sensor Group B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects wearing Harmony 1 Sensor will be assigned this group which will participate in the in-clinic YSI frequent sample testing 12 hours after sensor insertion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Harmony 1 Sensor</intervention_name>
    <description>Use of Harmony 1 Sensor for 10 days when inserted in the arm and abdomen and used with the Guardian Mobile in subjects aged 14-75 years who have had a diagnosis of type 1 or type 2 diabetes for at least 6 months.</description>
    <arm_group_label>Harmony 1 Sensor Group A</arm_group_label>
    <arm_group_label>Harmony 1 Sensor Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is 14 - 75 years of age at time of screening

          2. A clinical diagnosis of type 1 or 2 diabetes for a minimum of 6 months duration as
             determined via medical record or source documentation by an individual qualified to
             make a medical diagnosis

          3. Adequate venous access as assessed by investigator or appropriate staff

        Exclusion Criteria:

          1. Subject will not tolerate tape adhesive in the area of Harmony 1 Sensor placement as
             assessed by qualified individual.

          2. Subject has any unresolved adverse skin condition in the area of Harmony 1 Sensor or
             device placement (e.g., psoriasis, rash, Staphylococcus infection)

          3. Subject is actively participating in an investigational study (drug or device) wherein
             they have received treatment from an investigational study (drug or device) in the
             last 2 weeks

          4. Subject is female and has a positive pregnancy screening test

          5. Females of child bearing age and who are sexually active should be excluded if they
             are not using a form of contraception deemed reliable by investigator

          6. Subject is female and plans to become pregnant during the course of the study

          7. Subject has had a hypoglycemic seizure within the past 6 months

          8. Subject has had hypoglycemia resulting in loss of consciousness within the past 6
             months prior to screening visit.

          9. Subject has had an episode of diabetic ketoacidosis (DKA) within the past 6 months
             prior to screening visit.

         10. Subject has a history of a seizure disorder

         11. Subject has central nervous system or cardiac disorder resulting in syncope

         12. Subject has a history of myocardial infarction, unstable angina, coronary artery
             bypass surgery, coronary artery stenting, transient ischemic attack (TIA),
             cerebrovascular accident (CVA), angina, congestive heart failure, ventricular rhythm
             disturbances or thromboembolic disease

         13. Subject has a hematocrit (Hct) lower than the normal reference range

         14. Subject has a history of adrenal insufficiency.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Brazg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rainer Clinical Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Christiansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diablo Clinical Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2015</study_first_submitted>
  <study_first_submitted_qc>January 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2016</study_first_posted>
  <last_update_submitted>November 16, 2017</last_update_submitted>
  <last_update_submitted_qc>November 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 1 Diabetes</keyword>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Harmony Sensor</keyword>
  <keyword>Continuous Glucose Monitoring</keyword>
  <keyword>CGM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

